Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700014148

Trial Profile

Clinical Trials Insight: 700014148

Phase of Trial: Phase II

Latest Information Update: 03 Mar 2008

At a glance

  • Drugs NCX 4016 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors NicOx
  • Most Recent Events

    • 03 Mar 2008 Status change from planning to discontinued, as reported by a NicOx media release.
    • 31 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top